Company / Income Tax
ResMed Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$276.8M
FY2025
5-year range
$181.0M / $409.2M
FY2021-FY2025
Trend
+13.5%
vs FY2024
Sector context
#20 of 156
Health Care
What the data says
ResMed's income tax of $277M is higher than 87% of companies in the Health Care sector (FY2025). Income Tax has increased for 3 consecutive years, from $181M in FY2022 to $277M in FY2025.
Based on SEC 10-K filings.
$277M in FY2025 with a 5-year CAGR of +20.0%. Top quartile in the Health Care sector.
Increased from $204M to $277M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +20.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 156This company $276.8M Sector average $142.5M
▼
+94.3% above sector average
Key checks
Key Insights
- ResMed's income tax has grown for 3 consecutive years.
- 5-year CAGR of +20.0%, indicating consistent growth.
- In FY2025, income tax increased 13.5% year-over-year.
- Ranks #20 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $276.8M | +13.5% |
| FY2024 | $243.8M | +19.5% |
| FY2023 | $204.1M | +12.7% |
| FY2022 | $181.0M | -55.8% |
| FY2021 | $409.2M | +267.2% |
| FY2020 | $111.4M | -2.5% |
| FY2019 | $114.3M | -44.5% |
| FY2018 | $205.7M | +169.1% |
| FY2017 | $76.5M | -12.3% |
| FY2016 | $87.2M | +5.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026